Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
about
The costs of reducing loss to follow-up in South African cervical cancer screening.Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic ApproachPerformance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studiesCalibration methods used in cancer simulation models and suggested reporting guidelinesCost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities.Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of HondurasAre treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review.Knowledge, awareness and attitudes about cervical cancer among women attending or not an HIV treatment center in Lao PDR.Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in SwazilandSee-and-treat approaches to cervical cancer prevention for HIV-infected women.Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in KenyaHealth insurance and cervical cancer screening among older women in Latin American and Caribbean cities.Client satisfaction with cervical cancer screening in MalawiEstimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing studyCervical cancer prevention program in Jakarta, Indonesia: See and Treat model in developing country.Single-visit approach of cervical cancer screening: see and treat in IndonesiaCost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system.Knowledge, attitudes and practices regarding cervical cancer and screening among Haitian health care workers.Evaluation of a 5-year cervical cancer prevention project in Indonesia: opportunities, issues, and challenges.Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test.Estimating the cost of cervical cancer screening in five developing countriesTranslational approaches to improving cervical screening.Screening for cervical cancer in developing countries.Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups.Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.Delivering cervical cancer prevention services in low-resource settings.A critical assessment of screening methods for cervical neoplasia.Advocating for cervical cancer prevention.Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale.Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment ProgramsModeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.A public health approach to cervical cancer control: considerations of screening and vaccination strategies.Measurement in comparative effectiveness research.Cervical cancer screening among women who gave birth in the US-Mexico border region, 2005: the Brownsville-Matamoros Sister City Project for Women's Health.Socioeconomic determinants of cervical cancer screening in Latin AmericaQuality of life and its related factors among Iranian cervical cancer survivors.Decreasing the cancer burden in developing countries: concerns and recommendations.Analysis of the performance of 100% rapid review using an average time of 1 and 2 minutes according to the quality of cervical cytology specimens.
P2860
Q24815385-2B18CE43-828A-4748-90A2-BB94190278AAQ26779543-DE50B5E0-31F6-41B4-8E14-E07403FB6E3AQ28083434-2AF9AFA1-8A19-4F26-8F6B-BF1327EA81EFQ28749665-DC8CC593-9BA3-47B0-AA41-929D90318A50Q30235262-BE5CCC9B-DC7C-40A7-92CD-7C3B1AF2DDE8Q33299264-A7A6EA9B-AEAF-4CDE-8B4D-D820FDA30753Q33344903-115F12B1-C36E-40C0-8B74-6BE7BD7895CDQ33516805-96413191-60F1-4B4E-B736-CC7FA1454409Q33548529-2183BB59-EEC6-4244-BF95-F3DB26A01E96Q33591557-44825DF6-0CB0-4C7B-BF57-532B6906756FQ33713018-25044204-EE4F-49CE-992B-310578ADF8CEQ33754163-2AEEC550-A9EA-4A7E-A7A0-26A7CAD6F1A2Q33909353-8FE274BA-DF88-41A3-8E78-E829E5DF41AFQ33947749-753BE7AD-A997-4D2A-AA86-526B0B4AAB78Q34268184-55673662-DC9E-48BE-8231-7F29650EAA0AQ34280370-B036514C-358A-406A-B793-8B8EA6B2DD85Q34342550-84CA1761-CD79-4448-B4A9-83B5D7245DC8Q34360587-C33C8051-876B-44BE-8D1E-569D2A0BF96AQ34433755-B92EDE1E-DAA1-4F38-BA2C-24A951308243Q34578358-E5AD47EB-4E2D-4AD7-9ACB-B6272691EBC1Q34746804-F1FC3763-517C-4932-A343-971AC9C7BD85Q34765264-B5CED7B5-4125-472A-8223-DA227AF722DCQ35039416-1903C702-8FD8-4202-ADEE-06DAC7B46EC7Q35075785-B4CB61FC-0B7E-4082-AEAF-79C4147F0685Q35661162-10165E68-13A3-4D4D-A855-4924987AC88EQ35978042-592E357E-1310-4162-8AED-68F93F01ADA4Q36045104-4CFBD16A-BE31-4D1C-BF9F-B414BF0EE68BQ36095015-B263842D-19B2-48E7-A56A-DA5859CE582EQ36095029-C4501266-4069-4D28-86E7-53022551C003Q36095033-A74D8406-F57E-4DF7-919B-685CB31E64A1Q36195826-27BE223D-B2AE-478B-98E8-642F9C7D082CQ36241967-4CD658BF-1EF9-42BA-ABBE-224416481799Q36404994-139AE497-5D41-4215-97E8-D4FEE3C5D17EQ36727344-6F2E18A5-B663-42FD-8360-E4D008F2660AQ36781581-A43A276D-934C-4F15-81FB-8CCDE33414BFQ36962577-FBB82703-1EC1-4BCF-A3DA-415EEFB882E9Q37047487-989DE181-9F20-4907-9DD0-71E54C9919CBQ37204428-1EA618D2-CCE9-4AB5-8ADF-4256CD6F9A00Q37497489-FF827140-B271-43DA-A5AB-2CA72D861557Q37774398-C75D42B7-E535-4733-B317-EFB99824C708
P2860
Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Costs and benefits of differen ...... r in less-developed countries.
@en
Costs and benefits of differen ...... r in less-developed countries.
@nl
type
label
Costs and benefits of differen ...... r in less-developed countries.
@en
Costs and benefits of differen ...... r in less-developed countries.
@nl
prefLabel
Costs and benefits of differen ...... r in less-developed countries.
@en
Costs and benefits of differen ...... r in less-developed countries.
@nl
P2093
P2860
P356
P1476
Costs and benefits of differen ...... r in less-developed countries.
@en
P2093
Jason King
Jeanne S Mandelblatt
Khunying Kobchitt Limpahayom
Lynne Gaffikin
Patricia Ringers
Paul D Blumenthal
Pisake Lumbiganon
Suwanna Warakamin
William F Lawrence
P2860
P304
P356
10.1093/JNCI/94.19.1469
P407
P577
2002-10-01T00:00:00Z